105 related articles for article (PubMed ID: 12745460)
1. Adrenocortical tumours in children and adults: a study of pathological and proliferation features.
Sredni ST; Alves VA; Latorre Mdo R; Zerbini MC
Pathology; 2003 Apr; 35(2):130-5. PubMed ID: 12745460
[TBL] [Abstract][Full Text] [Related]
2. Texture image analysis in differentiating malignant from benign adrenal cortical tumors in children and adults.
Shirata NK; Sredni ST; Castelo A; Santinelli A; Mendonça B; Montironi R; Filho AL; Zerbini MC
Anticancer Res; 2009 Aug; 29(8):3365-8. PubMed ID: 19661357
[TBL] [Abstract][Full Text] [Related]
3. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
4. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
5. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
6. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
7. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
Gasińska A; Biesaga B; Kołodziejski L; Słonina D
Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
[TBL] [Abstract][Full Text] [Related]
8. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of AgNORs in bone tumours.
Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
[TBL] [Abstract][Full Text] [Related]
10. AgNOR expression in CNS neoplasms.
Husain N; Bagchi M; Husain M; Tiwari B
Indian J Pathol Microbiol; 1997 Oct; 40(4):503-9. PubMed ID: 9444862
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions in human adrenocortical disorders.
Sasano H; Saito Y; Sato I; Sasano N; Nagura H
Mod Pathol; 1990 Sep; 3(5):591-5. PubMed ID: 2235985
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumours.
Janczukowicz J
Folia Neuropathol; 2003; 41(2):97-101. PubMed ID: 12899202
[TBL] [Abstract][Full Text] [Related]
13. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
Chen M; Lee JC; Lo S; Shen J
Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
[TBL] [Abstract][Full Text] [Related]
14. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of nucleolar organizer regions in maxillary osteosarcoma.
Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
Acta Odontol Latinoam; 2007; 20(1):55-60. PubMed ID: 18046971
[TBL] [Abstract][Full Text] [Related]
17. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
19. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
